SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed the Intimation for loss of Share Certificate.11-02-2021
11-02-2021
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of copies of Newspaper Advertisement regarding Notice of the National Company Law Tribunal ('NCLT') Convened Meetings of the Sun Pharmaceutical Industries Limited ('the Company') as per letter attached.10-02-2021
Buy Sun Pharmaceutical Industries; target of Rs 700: Sharekhan
Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 700 in its research report dated January 29, 2021.09-02-2021
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 08, 2021 for Shanghvi Finance Pvt Ltd08-02-2021
Sun Pharma recalls 36,275 cartons of testosterone injection in US
As per the USFDA report, the affected lot of the intramuscular injections was manufactured by the drug maker in India and distributed in the US by Princeton, New Jersey-based Sun Pharmaceutical Industries Inc.07-02-2021
Buy Sun Pharmaceutical Industries; target of Rs 672: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 672 in its research report dated February 01, 2021.05-02-2021
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - NCLT Convened Meeting Of Equity Shareholders And Unsecured Creditors Of The Company On Tuesday, March 16, 2021 At 3.15 P.M. And 2.00 P.M. Respectively.
Please find enclosed respective Notices of NCLT Convened Meeting of equity shareholders and unsecured creditors of the Company to be held on Tuesday, March 16, 2021 at 3.15 p.m. and 2.00 p.m. respectively.05-02-2021
Hold Sun Pharmaceutical Industries; target of Rs 602: Prabhudas Lilladher
Prabhudas Lilladher recommended hold rating on Sun Pharmaceutical Industries with a target price of Rs 602 in its research report dated January 28, 2021.04-02-2021
Buy Sun Pharma; target of Rs 740: Motilal Oswal
Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 740 in its research report dated January 30, 2021.03-02-2021
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 read with Schedule III and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we have published an advertisement giving Notice of the Record Date for the purpose of payment of Interim Dividend for the financial year 2020-21 in all the editions of Financial Express dated January 30, 2021 and in Ahmedabad Edition (Gujarati Language) of Financial Express dated January 30, 2021. We are enclosing herewith copy of the advertisement published in the following newspapers: 1. Financial Express dated January 30, 2021- Mumbai Edition 2. Financial Express dated January 30, 2021- Ahmedabad Edition 3. Financial Express dated January 30, 2021- Ahmedabad Edition (Gujarati Language) This is for your information and dissemination.30-01-2021